HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 1, 2015, Pages 49-58

  Van Hemelen, D ^a   Mahler, V ^b   Fischer, G ^c   Fae, I ^c   Reichl Leb, V ^c,d   Pickl, W ^c,d   Jutel, M ^e   Smolinska, S ^e   Ebner, C ^f   Bohle, B ^a,c   Jahn Schmid, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

^f Allergie Ambulatorium Rennweg Vienna   (Austria)

Author keywords

allergens and epitopes; immunologic tests; T cells

Indexed keywords

ALLERGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CYTOKINE; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; PEPTIDE; TETRAMER; PLANT ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTEMISIA VULGARIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; JURKAT CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; TH2 CELL; ADVERSE EFFECTS; AMINO ACID SEQUENCE; CHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; POLLEN; PROTEIN MULTIMERIZATION; RHINITIS, ALLERGIC, SEASONAL;

ALLERGENS; AMINO ACID SEQUENCE; ANTIGENS, PLANT; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PHENOTYPE; POLLEN; PROTEIN MULTIMERIZATION; RHINITIS, ALLERGIC, SEASONAL; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 84915749618     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12524     Document Type: Article

References (34)

1. Romagnani S,. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000; 105: 399-408.
2. Akdis CA, Akdis M,. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127: 18-27.
3. Van Hemelen D, Oude Elberink JN, Bohle B, Heimweg J, Nawijn MC, van Oosterhout AJ,. Flow cytometric analysis of cytokine expression in short-term allergen-stimulated T cells mirrors the phenotype of proliferating T cells in long-term cultures. J Immunol Methods 2011; 371: 114-121.
4. Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK,. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 1999; 230: 99-112.
5. Bonvalet M, Wambre E, Moussu H, Horiot S, Kwok WW, Louise A, et al. Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4(+) T cells. Clin Exp Allergy 2011; 41: 821-829.
6. Parviainen S, Taivainen A, Liukko A, Nieminen A, Rytkonen-Nissinen M, Kinnunen T, et al. Comparison of the allergic and nonallergic CD4 + T-cell responses to the major dog allergen Can f 1. J Allergy Clin Immunol 2010; 126: 406-408.
7. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94-96.
8. Novak EJ, Liu AW, Nepom GT, Kwok WW,. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest 1999; 104: R63-R67.
9. Crawford F, Kozono H, White J, Marrack P, Kappler J,. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 1998; 8: 675-682.
10. Boniface JJ, Rabinowitz JD, Wulfing C, Hampl J, Reich Z, Altman JD, et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity 1998; 9: 459-466.
11. Kwok WW,. Challenges in staining T cells using HLA class II tetramers. Clin Immunol 2003; 106: 23-28.
12. Wambre E, Delong JH, James EA, Torres-Chinn N, Pfutzner W, Mobs C, et al. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2014; 133: 872-879.
13. Macaubas C, Wahlstrom J, Galvao da Silva AP, Forsthuber TG, Sonderstrup G, Kwok WW, et al. Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 2006; 176: 5069-5077.
14. Van Overtvelt L, Wambre E, Maillere B, von Hofe E, Louise A, Balazuc AM, et al. Assessment of Bet v 1-specific CD4 + T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008; 180: 4514-4522.
15. Bateman EA, Ardern-Jones MR, Ogg GS,. Persistent central memory phenotype of circulating Fel d 1 peptide/DRB10101 tetramer-binding CD4 + T cells. J Allergy Clin Immunol 2006; 118: 1350-1356.
16. DeLong JH, Simpson KH, Wambre E, James EA, Robinson D, Kwok WW,. Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 2011; 127: 1211-1218.
17. Kinnunen T, Nieminen A, Kwok WW, Narvanen A, Rytkonen-Nissinen M, Saarelainen S, et al. Allergen-specific naive and memory CD4 + T cells exhibit functional and phenotypic differences between individuals with or without allergy. Eur J Immunol 2010; 40: 2460-2469.
18. Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F, et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. Faseb J 2003; 17: 106-108.
19. Jahn-Schmid B, Kelemen P, Himly M, Bohle B, Fischer G, Ferreira F, et al. The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 2002; 169: 6005-6011.
20. Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A, et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB101. J Allergy Clin Immunol 2005; 115: 399-404.
21. Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, Schreiner W, et al. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Mol Immunol 2009; 46: 1839-1844.
22. Jahn-Schmid B, Sirven P, Leb V, Pickl WF, Fischer GF, Gadermaier G, et al. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J Immunol 2008; 181: 3636-3642.
23. Leb VM, Jahn-Schmid B, Schmetterer KG, Kueng HJ, Haiderer D, Neunkirchner A, et al. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. J Allergy Clin Immunol 2008; 121: 64-71.
24. Wambre E, Van Overtvelt L, Maillere B, Humphreys R, von Hofe E, Ferhat L, et al. Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol 2008; 146: 99-112.
25. Gupta S, Hopner S, Rupp B, Gunther S, Dickhaut K, Agarwal N, et al. Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS ONE 2008; 3: e1814.
26. Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012; 170: 202-211.
27. Cecconi V, Moro M, Del Mare S, Dellabona P, Casorati G,. Use of MHC class II tetramers to investigate CD4 + T cell responses: problems and solutions. Cytometry A 2008; 73: 1010-1018.
28. Cameron TO, Cochran JR, Yassine-Diab B, Sekaly RP, Stern LJ,. Cutting edge: detection of antigen-specific CD4 + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J Immunol 2001; 166: 741-745.
29. Lissina A, Ladell K, Skowera A, Clement M, Edwards E, Seggewiss R, et al. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods 2009; 340: 11-24.
30. Kwok WW, Roti M, Delong JH, Tan V, Wambre E, James EA, et al. Direct ex vivo analysis of allergen-specific CD4 + T cells. J Allergy Clin Immunol 2010; 125: 1407-1409.
31. Wambre E, Bonvalet M, Bodo VB, Maillere B, Leclert G, Moussu H, et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses. Clin Exp Allergy 2011; 41: 192-203.
32. Crack LR, Chan HW, McPherson T, Ogg GS,. Phenotypic analysis of perennial airborne allergen-specific CD4 + T cells in atopic and non-atopic individuals. Clin Exp Allergy 2011; 41: 1555-1567.
33. Wambre E, DeLong JH, James EA, LaFond RE, Robinson D, Kwok WW,. Differentiation stage determines pathologic and protective allergen-specific CD4 + T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol 2012; 129: 544-551.
34. Sabatino JJ Jr, Huang J, Zhu C, Evavold BD,. High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4 + T cell responses. J Exp Med 2011; 208: 81-90.